Literature DB >> 22130873

Analyzing cancer samples with SNP arrays.

Peter Van Loo1, Gro Nilsen, Silje H Nordgard, Hans Kristian Moen Vollan, Anne-Lise Børresen-Dale, Vessela N Kristensen, Ole Christian Lingjærde.   

Abstract

Single nucleotide polymorphism (SNP) arrays are powerful tools to delineate genomic aberrations in cancer genomes. However, the analysis of these SNP array data of cancer samples is complicated by three phenomena: (a) aneuploidy: due to massive aberrations, the total DNA content of a cancer cell can differ significantly from its normal two copies; (b) nonaberrant cell admixture: samples from solid tumors do not exclusively contain aberrant tumor cells, but always contain some portion of nonaberrant cells; (c) intratumor heterogeneity: different cells in the tumor sample may have different aberrations. We describe here how these phenomena impact the SNP array profile, and how these can be accounted for in the analysis. In an extended practical example, we apply our recently developed and further improved ASCAT (allele-specific copy number analysis of tumors) suite of tools to analyze SNP array data using data from a series of breast carcinomas as an example. We first describe the structure of the data, how it can be plotted and interpreted, and how it can be segmented. The core ASCAT algorithm next determines the fraction of nonaberrant cells and the tumor ploidy (the average number of DNA copies), and calculates an ASCAT profile. We describe how these ASCAT profiles visualize both copy number aberrations as well as copy-number-neutral events. Finally, we touch upon regions showing intratumor heterogeneity, and how they can be detected in ASCAT profiles. All source code and data described here can be found at our ASCAT Web site ( http://www.ifi.uio.no/forskning/grupper/bioinf/Projects/ASCAT/).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22130873     DOI: 10.1007/978-1-61779-400-1_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Guidelines for cytogenetic investigations in tumours.

Authors:  Rosalind J Hastings; Nick Bown; Maria G Tibiletti; Maria Debiec-Rychter; Roberta Vanni; Blanca Espinet; Nadine van Roy; Paul Roberts; Eva van den Berg-de-Ruiter; Alain Bernheim; Jacqueline Schoumans; Steve Chatters; Zuzana Zemanova; Marian Stevens-Kroef; Annet Simons; Sverre Heim; Marta Salido; Bauke Ylstra; David R Betts
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

2.  Poor survival with wild-type TP53 ovarian cancer?

Authors:  Kwong-Kwok Wong; Daisy I Izaguirre; Suet-Yan Kwan; Erin R King; Michael T Deavers; Anil K Sood; Samuel C Mok; David M Gershenson
Journal:  Gynecol Oncol       Date:  2013-06-22       Impact factor: 5.482

3.  The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.

Authors:  A Pemov; H Li; R Patidar; N F Hansen; S Sindiri; S W Hartley; J S Wei; A Elkahloun; S C Chandrasekharappa; J F Boland; S Bass; J C Mullikin; J Khan; B C Widemann; M R Wallace; D R Stewart
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  Genomic hallmarks of localized, non-indolent prostate cancer.

Authors:  Michael Fraser; Veronica Y Sabelnykova; Takafumi N Yamaguchi; Lawrence E Heisler; Julie Livingstone; Vincent Huang; Yu-Jia Shiah; Fouad Yousif; Xihui Lin; Andre P Masella; Natalie S Fox; Michael Xie; Stephenie D Prokopec; Alejandro Berlin; Emilie Lalonde; Musaddeque Ahmed; Dominique Trudel; Xuemei Luo; Timothy A Beck; Alice Meng; Junyan Zhang; Alister D'Costa; Robert E Denroche; Haiying Kong; Shadrielle Melijah G Espiritu; Melvin L K Chua; Ada Wong; Taryne Chong; Michelle Sam; Jeremy Johns; Lee Timms; Nicholas B Buchner; Michèle Orain; Valérie Picard; Helène Hovington; Alexander Murison; Ken Kron; Nicholas J Harding; Christine P'ng; Kathleen E Houlahan; Kenneth C Chu; Bryan Lo; Francis Nguyen; Constance H Li; Ren X Sun; Richard de Borja; Christopher I Cooper; Julia F Hopkins; Shaylan K Govind; Clement Fung; Daryl Waggott; Jeffrey Green; Syed Haider; Michelle A Chan-Seng-Yue; Esther Jung; Zhiyuan Wang; Alain Bergeron; Alan Dal Pra; Louis Lacombe; Colin C Collins; Cenk Sahinalp; Mathieu Lupien; Neil E Fleshner; Housheng H He; Yves Fradet; Bernard Tetu; Theodorus van der Kwast; John D McPherson; Robert G Bristow; Paul C Boutros
Journal:  Nature       Date:  2017-01-09       Impact factor: 49.962

5.  Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.

Authors:  Ramita Dewan; Alex Pemov; H Jeffrey Kim; Keaton L Morgan; Raul A Vasquez; Prashant Chittiboina; Xiang Wang; Settara C Chandrasekharappa; Abhik Ray-Chaudhury; John A Butman; Douglas R Stewart; Ashok R Asthagiri
Journal:  Neuro Oncol       Date:  2014-12-01       Impact factor: 12.300

6.  ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data.

Authors:  Keiran M Raine; Peter Van Loo; David C Wedge; David Jones; Andrew Menzies; Adam P Butler; Jon W Teague; Patrick Tarpey; Serena Nik-Zainal; Peter J Campbell
Journal:  Curr Protoc Bioinformatics       Date:  2016-12-08

Review 7.  DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Synne Torkildsen; Geir E Tjønnfjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

8.  Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.

Authors:  Mathew A Sloane; Jason W H Wong; Dilmi Perera; Andrea C Nunez; John E Pimanda; Nicholas J Hawkins; Oliver M Sieber; Michael J Bourke; Luke B Hesson; Robyn L Ward
Journal:  Epigenetics       Date:  2014-05-16       Impact factor: 4.528

9.  EZH2 mutations are frequent and represent an early event in follicular lymphoma.

Authors:  Csaba Bödör; Vera Grossmann; Nikolay Popov; Jessica Okosun; Ciarán O'Riain; King Tan; Jacek Marzec; Shamzah Araf; Jun Wang; Abigail M Lee; Andrew Clear; Silvia Montoto; Janet Matthews; Sameena Iqbal; Hajnalka Rajnai; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Erlend B Smeland; Wing C Chan; Rita M Braziel; Louis M Staudt; George Wright; T Andrew Lister; Olivier Elemento; Robert Hills; John G Gribben; Claude Chelala; András Matolcsy; Alexander Kohlmann; Torsten Haferlach; Randy D Gascoyne; Jude Fitzgibbon
Journal:  Blood       Date:  2013-09-19       Impact factor: 22.113

10.  Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry.

Authors:  Alia Albawardi; Julie Livingstone; Saeeda Almarzooqi; Nallasivam Palanisamy; Kathleen E Houlahan; Aktham Adnan Ahmad Awwad; Ramy A Abdelsalam; Paul C Boutros; Tarek A Bismar
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.